C12N 2501/734
Proteases
Official title: Proteases (EC 3.4.)
C12N2501/734 (Proteases) appears on 91 US grants and 220 published applications in this corpus.
Search patents in C12N- Granted patents
- 91
- Published applications
- 220
- Assignees
- 154
- Inventors
- 482
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 5 |
| 2012 | 1 | 4 |
| 2013 | 1 | 5 |
| 2014 | 2 | 7 |
| 2015 | 8 | 15 |
| 2016 | 7 | 19 |
| 2017 | 3 | 13 |
| 2018 | 12 | 12 |
| 2019 | 8 | 18 |
| 2020 | 5 | 21 |
| 2021 | 4 | 11 |
| 2022 | 9 | 18 |
| 2023 | 7 | 14 |
| 2024 | 13 | 16 |
| 2025 | 6 | 22 |
| 2026 | 5 | 14 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for production of platelets from pluripotent stem cells and compositions thereof4 Aug 2026US RE50,977 E1Astellas Institute for Regenerative Medicine
- Methods for preparing tumor-infiltrating lymphocytes7 Jul 2026US 12,674,136 B2Shanghai AbelZeta Ltd.
- Methods for production of platelets from pluripotent stem cells and compositions thereof16 Jun 2026US 12,653,840 B2Astellas Institute for Regenerative Medicine
- Methods for production of platelets from pluripotent stem cells and compositions thereof16 Jun 2026US RE50,916 E1Astellas Institute for Regenerative Medicine
- Specification of functional cranial placode derivatives from human pluripotent stem cells5 May 2026US 12,618,044 B2Memorial Sloan Kettering Cancer Center
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Compositions and methods for treatment of spaceflight-associated mitochondrial damage6 Aug 2026US 2026/0224617 A1The Sallie Astor Burdine Breast Foundation
- Method for preparing cell membrane biomimetic drug delivery system targeting atherosclerotic lesions, and product and use thereof23 Jul 2026US 2026/0207521 A1The Third Affiliated Hospital, Guangzhou Medical University (Guangzhou Medical Center for Critical
- Culture methods23 Jul 2026US 2026/0209693 A1
Most cited
By later US patents
- Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production77US 8,129,182 B2ViaCyte, Inc. · 2012
- Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production37US 8,603,811 B2ViaCyte, Inc. · 2013
- Methods for production of platelets from pluripotent stem cells and compositions thereof18US 9,763,984 B2Astellas Institute for Regenerative Medicine · 2017
- Methods for production of platelets from pluripotent stem cells and compositions thereof17US 10,426,799 B2Astellas Institute for Regenerative Medicine · 2019
- Methods for production of platelets from pluripotent stem cells and compositions thereof17US 9,993,503 B2Astellas Institute for Regenerative Medicine · 2018